Should "standard gamble" and "time trade off" utility measurement be used more in mental health research?

Journal of Mental Health Policy and Economics

Volumn 13, Issue 2, 2010, Pages

  Flood, Chris ^a,b  

^a Mental Health City University   (United Kingdom)

^b NATIONAL PATIENT SAFETY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE POLICY; HEALTH STATUS; HOSPITAL ADMISSION; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MENTAL DISEASE; MENTAL HEALTH RESEARCH; MENTAL HEALTH SERVICE; METHODOLOGY; QUALITY ADJUSTED LIFE YEAR; REVIEW; RISK ASSESSMENT; CONSUMER ATTITUDE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE DELIVERY; HEALTH SERVICES RESEARCH; HUMAN; ORGANIZATION; RESOURCE ALLOCATION; SCHIZOPHRENIA; STATISTICS AND NUMERICAL DATA; UNITED STATES;

CONSUMER SATISFACTION; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; DELIVERY OF HEALTH CARE; HEALTH SERVICES RESEARCH; HUMANS; MENTAL HEALTH SERVICES; QUALITY-ADJUSTED LIFE YEARS; RESOURCE ALLOCATION; SCHIZOPHRENIA; UNITED STATES; CONSUMER BEHAVIOR;

EID: 77955059176     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Torrance GW. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989; 5: 559-575.
2. Gamelin A, Muñoz Sastre MT, Sorum PC, Mullet E. Eliciting utilities using functional methodology: people's disutilities for the adverse outcomes of cardiopulmonary resuscitation. Qual Life Res 2006; 15(3): 429-439.
3. Tversky A, Kahneman D. The Framing of Decisions and the Psychology of Choice. Science 1981 Jan 30; 211(4481): 453-458.
4. Care Quality Commission (2009). Mental health services. Key Findings from 2009 national survey of mental health acute inpatient services in England. http://www.cqc.org.uk/usingcareservices/healthcare/patientsurveys/ mentalhealthservices.cfm
5. National Patient Safety Agency (England and Wales) (Web site accessed January 2010). http://www.nrls.npsa.nhs.uk/resources/clinical-specialty/mental- health/
6. Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health 2006; 9(4): 213-218.
7. Bennett KJ, Torrance GW, Boyle MH, Guscott R. Cost-Utility Analysis in Depression: The McSad Utility Measure for Depression Health States. Psychiatr Serv 2000; 51: 1171-1176.
8. Morimoto T, Fukui T. Utilities measured by rating scale, time trade-off, and standard gamble: Review and reference for health care professionals. J Epidemiol 2002; 12: 160-178.
9. Revicki DA, Hanlon J, Martin S, Gyulai L, Ghaemi SN, Lynch F, Mannix S, Kleinman L. Patient-based utilities for bipolar disorder-related health states. J Affect Disord 2005; 87: 203-210.
10. Voruganti LN, Awad AG, Oyewumi LK, Cortese L, Zirul S, Dhawan R. Assessing Health Utilities in Schizophrenia: A Feasibility Study. Pharmacoeconomics 2000; 17(3): 273-286.
11. Briggs A, Wild D, Less M, Reaney M, Dursun S, Parry D, Mukherjee J. Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation. Health Qual Life Outcomes 2008; 6: 105.
12. Konig HH, Gunther OH, Angermeyer MC, Roick C. Utility Assessment in Patients with Mental Disorders. Validity and Discriminative Ability of the Time Trade-Off Method. Pharmacoeconomics 2009; 27(5): 405-419.
13. Shumway M, Chouljian TL, Battle CL. Measuring Preferences for Schizophrenia Outcomes with the Time Tradeoff Method. J Behav Health Serv Res 2005; 32(1): 14-26.
14. Lloyd AJ. The extent of patients' understanding of the risk of treatments. Qual Health Care 2001; 10(Suppl 1): i14-i18.
15. Edwards A, Elwyn G, Covey J, Matthews E, Pill R. Presenting Risk Information A Review of the Effects of Framing and other Manipulations on Patient Outcomes. J Health Commun 2001; 6(1): 61-82.
16. Reventlow S, Hvas AC, Tulinius C. "In really great danger ..." The concept of risk in general practice. Scand J Prim Health Care 2001; 19: 71-75.
17. Henwood K, Pidgeon N, Sarre S, Simmons P, Smith N. Risk, framing and everyday life: Epistemological and methodological reflections from three socio-cultural projects. Health Risk Soc 2008; 10(5): 421-438.
18. Lenert LA, Sturley AP, Rapaport MH, Chavez S, Mohr PE, Rupnow M. Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores. Schizophr Res 2004; 71: 155-165.
19. Lloyd AJ, Hayes PD, Bell PRF. The role of risk and benet perception in informed consent for surgery. Med Decis Making 2001; 21:141-149.
20. Stiggelbout AM, Kiebert GM, Kievit J, Leer JWH, Stoter G, De Haes JCJM. Utility Assessment in Cancer Patients. Adjustment of Time Tradeoff Scores for the Utility of Life Years and Comparison with Standard Gamble Scores. Med Decis Making 1994; 14(1): 82-90.
21. Schaffer A, Levitt AJ, Hershkop SK, Oh P, MacDonald C, Lanctot K. Utility scores of symptom profiles in major depression. Psychiatry Res 2002; 110: 189-197.
22. Gattellari M, Butow PN, Tattersall MH, Dunn SM, MacLeod CA. Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol 1999; 10: 39-46.
23. Elwyn G, Edwards A, Eccles M, Rovner D. Decision analysis in patient care. Lancet 2001 Aug 18; 358(9281): 571-574.
24. Neumann VJ, Morgenstern O. (2007). Theory of Games and Economic Behavior. Princeton and Oxford. Princeton University Press. Sixtieth-Anniversary Edition.
25. Ubel PA, Lowenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state. evaluations of patients and the general public. Qual Life Res 2003; 12(6): 599-607.
26. Lenert LA, Treadwell JR, Schwartz CE. Associations between Health Status and Utilities Implications for Policy. Med Care 1999; 37(5): 479-89.
27. Stalmeier PF, Goldstein MK, Holmes AM, Lenert L, Miyamoto J, Stiggelbout AM, Torrance GW, Tsevat J. What Should Be Reported in a Methods Section on Utility Assessment? Med Decis Making 2001; 21(3): 200-207.
28. http://www.euroqol.org/ (2008).
29. Hawthorne G, Richardson J. Measuring the value of program outcomes: a review of multiattribute utility measures. Expert Rev Pharmacoecon Outcomes Res 2001; 1(2): 215-228.
30. Lamers M, Bouwmans CAM, van Straten A, Donker MCH, Hakkaart L. Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ 2006; 15: 1229-1236.
31. Dolan P, Gudex C, Kind P, Williams A. Valuing health states: A comparison of methods. J Health Econ 1996; 15(2): 209-231.
32. Bleichrodt H. A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ 2002; 11(5): 447-56.
33. Quiggin J. A theory of Anticipated Utility. J Econ Behav Organ 1982; p. 323-343.
34. Saarni SI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, Lonnqvist J. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 2007; 190: 326-332.
35. Revicki DA, Wood M. Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J Affect Disord 1998; 48(1): 25-36.
36. Pyne JM, Patterson TL, Kaplan RM, Ho S, Gillin JC, Golshan S, Grant I. Preliminary longitudinal assessment of quality of life in patients with major depression. Psychopharmacol Bull 1997; 33(1): 23-29. (Pubitemid 27184191)
37. Pyne JM, Patterson TL, Kaplan RM, Gillin JC, Koch WL, Grant I. Assessment of the quality of life of patients with major depression. Psychiatr Serv 1997; 48: 224-230.
38. Revicki DA, Shakespeare A, Kind P. Preferences for schizophrenia-related health states: a comparison of patients, caregivers and psychiatrists. Int Clin Psychopharmacol 1996; 11(2): 101-108.
39. Patrick DL, Mathias SD, Elkin EP. (1995). Health State Preferences of Persons with Anxiety. Technology Assessment Group, San Francisco, CA.
40. Mauskopf J. (2006) Utility Assessment. RTI on-line publication. http://www.rtihs.org/images
41. Mauskopf J, Simon G, Nimsch C, Krishnan AA. (2006) RTI Health Solutions. ISPOR poster presentation. http://www.rtihs.org/request/index.cfm?fuseaction= display&PID=6501/Utility-Assessment-jm-5-2-06.pdf
42. Chouinard G & Albright PS. Economic and health state utility determinations for schizophrenia patients treated with risperidone or haloperidol. J Clin Psychopharmacol 1997; 17: 298-307.
43. Wells KB, Sherbourne CD. Functioning and Utility for Current Health of Patients With Depression or Chronic Medical Conditions in Managed, Primary Care Practices. Arch Gen Psychiatry 1999; 56: 897-904.
44. Lenert LA, Morss S, Goldstein MK, Bergen MR, Faustman WO, Garber AM. Measurement of the Validity of Utility Elicitations Performed by Computerized Interview. Med Care 1997; 35(9): 915-920
45. Rosser R & Kind P. A scale of valuations of states of illness: Is there a social consensus? Int J Epidemiol 1978; 7: 347-358.
46. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. Br Med J 2004 Jul 24; 329 (7459): 224-227.
47. Rasanen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynanen O-P, Roine R P Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. Italian Journal of Public Health 2005; 2: 280.
48. Kind P. (2006) Be Reasonable: Following the Williams' Way. A Conference to Celebrate the Work of Alan Williams. Putting the "Q" in QALYs. Conference Paper.
49. Petrou S. (2001) What are health utilities? http://www.medicine.ox.ac.uk/ bandolier/painres/download/whatis/Health-util.pdf Volume 1, (4).
50. Conner TM, Crismon ML, Still DJ. A critical review of selected pharmacoeconomic analyses of antidepressant therapy. Ann Pharmacother 1999; 33(3): 364-372.
51. Fleischhacker WW, Meise U, Günther V, Kurz M. Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr Scand 1994; 89: 11-15.
52. Tsevat J, Dawson NV, Wu AW, Lynn J, Soukup JR, Cook EF, Vidaillet H, Phillips RS. Health values of hospitalized patients 80 years or older. JAMA 1998 Feb 4; 279(5): 371-375. (Pubitemid 28133866)
53. Mulley AG. Assessing Patients' Utilities. Can the Ends Justify the Means? Med Care 1989; 27(3 Suppl): S269-81.